Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

BioCryst Pharmaceuticals (BCRX): Q4 EPS of -$0.29 beats by $0.04. Revenue of $5.2M (-68.9% Y/Y)...

  • Thursday, February 16, 2012, 7:49 AM ET
    BioCryst Pharmaceuticals (BCRX): Q4 EPS of -$0.29 beats by $0.04. Revenue of $5.2M (-68.9% Y/Y) misses by $2.2M. (PR)
Other date
DJIA (DIA) S&P 500 (SPY)